Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/02/2005CN1691939A Compositions for diabetes
11/02/2005CN1691936A Combined immediate release and extended release analgesic composition
11/02/2005CN1691935A Ascorbic acid salt suspensions and use thereof as antioxidants
11/02/2005CN1691931A Topical compositions having a natural ingredient and method of use
11/02/2005CN1690073A Steroid derivatives
11/02/2005CN1690051A Novel azoles having an insecticidal action
11/02/2005CN1690041A Novel derivatives of 3, 3-diphenylpropylamines
11/02/2005CN1689583A Moderate molecular weighted chondroitin sulfate injection and its preparing process
11/02/2005CN1689582A Azitromycin particle and method for preparing its enteric coated formulation
11/02/2005CN1689581A Novel usage of jasminoidin
11/02/2005CN1689580A Cardiac and cerebral vascular disease treating medicinal composition
11/02/2005CN1689579A Application of burdock glycoside or its aglycon in preparation of medicine for treating diabetes or its complications
11/02/2005CN1689578A Application of beta sodium aescine in preparation of medicine for treating leukemia
11/02/2005CN1689577A Therapeutic function of oligosaccharide like alpha galactoside for uremia
11/02/2005CN1689576A Magnetic slow release 5-aminosalicylic acid with intercalate structure and its preparation method
11/02/2005CN1689575A Application of ocotillol in the preparing process of medicine for treating or preventing cardiovascular and cerebrovascular disease
11/02/2005CN1689574A Application of alisol B23-mono acetic ester and alisma rhizome extract in reversal of cancer cell multi-drug tolerance
11/02/2005CN1689573A Inclusion preparation of levosimendan and beta cyclodextrin
11/02/2005CN1689572A Usage of naloxone hydrochloride in preparation of medicine for treating hypertensive cerebral hemorrhage
11/02/2005CN1689571A Usage of naloxone hydrochloride in preparation of medicine for treating senility study memory disturbance
11/02/2005CN1689570A Novel usage of naloxone hydrochloride in pharmacy
11/02/2005CN1689569A Pharmaceutical composition with sustained release function and its preparing process
11/02/2005CN1689568A Pharmaceutical composition containing cyclodextrin derivatives and proton pump inhibitor of parietal cell
11/02/2005CN1689567A Enteric coated micro particle preparation of omeprazole and its preparation method
11/02/2005CN1689566A Compound oral preparation of carvedilol and benidipine
11/02/2005CN1689565A Cold resistance compound rimantadine preparation
11/02/2005CN1689564A Vitamin C composition containing sodium vitamin C
11/02/2005CN1689563A Application of butylbenzene phthalein homolog in preparation of medicine for treating cerebral ischemia disease
11/02/2005CN1689562A Application of poloxamer in preparation of novel sodium houttuynine injection
11/02/2005CN1689561A Freeze dry preparation containing diclofenac salt and lidocaine and its preparation method
11/02/2005CN1689560A Agents for fattening animals
11/02/2005CN1689559A Usage of veratramin as signal transduction inhibitor
11/02/2005CN1689558A Preparation method of cordate houttuynia injection and quality control method thereof
11/02/2005CN1689431A Beverage for fattening animals
11/02/2005CN1225476C Human cervical cancer 1 protooncogene and protein encoded therein
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/02/2005CN1225469C Di (N-chlorolactamic acid) potassium platinate, its preparation method and its application
11/02/2005CN1225467C Diazocines compound and method for preparing it using slime bacteria fermentation and extraction method
11/02/2005CN1225466C Sodium-hydrogen exchanger type 1 inhibitor (NHE-1)
11/02/2005CN1225465C Novel compounds
11/02/2005CN1225464C Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
11/02/2005CN1225463C Arylated furane and thenoyl amine with potassium channel blocking effect
11/02/2005CN1225462C New piperazine and piperidine compounds
11/02/2005CN1225459C NItroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
11/02/2005CN1225458C Catalytic reduction of acetylene hydrocarbon compound
11/02/2005CN1225286C Short interference ribonucleic acid as novel anti-tumor gene therapeutic medicine
11/02/2005CN1225267C Medicine for treating endocrine infiltrative exophthalmos
11/02/2005CN1225252C Process for preparing composition comprising medicinal herb extract for preventing and treating arthritis and composition thereof
11/02/2005CN1225250C Efficacious parts compositions of Chinese medicine for prevention and treatment of senile dementia and preparation method
11/02/2005CN1225249C Antivirus medicine for raising immunity and its preparation method
11/02/2005CN1225248C Antineoplastic effect of a group of cycloart-one triterpene compound
11/02/2005CN1225247C Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn.
11/02/2005CN1225246C Releasing improved pharmaceutical preparation containing amoxicillin
11/02/2005CN1225245C Use of Pidotimod in preparation of hepatitis B treating medicine
11/02/2005CN1225244C Composite blood pressure reducing preparation containing indapamide and beta retarder or beta and alpha retarder
11/02/2005CN1225243C Fluid for dispelling prickly heat and dermatitis and preparation method
11/02/2005CN1225242C Erianin fat emulsion as antineoplastic medicine and preparing process thereof
11/02/2005CN1225236C Anti-germ attachment-composition
11/01/2005US6960692 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960687 Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and CNS activity, and method for their preparation
11/01/2005US6960683 Antiinflammatory agents; autoimmune diseases; cardiovascular disorders
11/01/2005US6960681 Guanidinomethyl cyclohexane carboxylic acid ester derivatives
11/01/2005US6960678 Silanol enzyme inhibitors
11/01/2005US6960674 A lipoxin compound for treating polymorphoneutrophil (PMN) inflammation
11/01/2005US6960664 Aza hydroxylated ethyl amine compounds
11/01/2005US6960661 [7-(3-chloro-4-methoxybenzlamino)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-ylmethoxy]acetic acid, synthesis thereof and intermediates used therein
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960615 For treatment of acne, psoriasis, seborrhea, ingrown hairs, pseudofolliculitis barbae, and hyperpigmented skin
11/01/2005US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids
11/01/2005US6960613 administering (S)-1-[3-(dimethyl-amino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile or a salt; selective, centrally acting serotonin reuptake inhibitor for panic attacks and obsessive compulsive disorders
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960610 Hypotensive agents; antiischemic agents; antiarrhythmia agents
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960608 Fused indazoles and indoles and their use for the treatment of glaucoma
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960600 a triazole or amidazole compound containing oxy, hydroxy or aromatic rings; active on candidoses, cryptococcoses caused by Candida albicans; prevention of mycosic diseases in individuals with immunodeficiency.
11/01/2005US6960599 Dopamine D2 receptor and 5-HT1A antagonists; schizophrenia; cognitive activators; Alzheimer's disease; brain disorders; strokes; antiischemic agents; anxiolytic agents; obsessive compulsive disorder; eating, sleeping and sexual disorders
11/01/2005US6960596 Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancer
11/01/2005US6960592 erectile dysfunction; halosulfonation of 2-ethoxy benzoic acid, sulfonamidation, haloacylation, deacylation and amidation, cyclization; phosphodiesterase inhibitor; side-effect reduction; long lasting
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960590 Orally active salts with tyrosine kinase activity
11/01/2005US6960589 Administering to a mammal suffering from sexual disorder a benzimidazole derivative containing piperazine or piperidine ring
11/01/2005US6960588 Tryptase inhibitors
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960584 Inhibitors of Akt activity
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960577 Combination therapy for treatment of refractory depression
11/01/2005US6960571 Methods and compositions for administration of iron for the treatment of restless leg syndrome
11/01/2005US6960569 Hepatitis C virus non-structural NS3/4A fusion gene
11/01/2005US6960568 Nucleosides and related processes, pharmaceutical compositions and methods
11/01/2005US6960564 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960360 Using plant extract for extraction, purification and prepartion of composition enriched in flavonoids; viricides; bactericides; antiinflammatory/antiarthritic agents
1 ... 4485 4486 4487 4488 4489 4490 4491 4492 4493 4494 4495 4496 4497 4498 4499 4500 4501 4502 4503 4504 4505 ... 7860